Fetal growth restriction

There are 72 papers on fetal growth restriction in aging research: 1 trial and 16 observational studies in people, 28 in animals, 1 in cells, 24 reviews. The newest story, Oct 24, 2026: “Food contaminant restricts fetal growth in mice”.

Disease

72 papers study it5 more mention it24 findings

8 new papers in 30 daysSee all 77 papers on fetal growth restriction

“after FGR the increased risk of atherosclerosis was most notable.”
Cardiovascular Disease in Women the Two Decades Following Uteroplacental Disorders: A Population‐Based Data‐Linkage StudyBJOG : an international journal of obstetrics and gynaecology2026doi:10.1111/1471-0528.70363
  • Human trial1
  • Humans16
  • Animals28
  • Cells1

Interventions

6

Nicotinamide riboside

downin rats1downin rodent1

2 studies
  1. Nicotinamide riboside prevents fetal growth restriction in rats (LPS-induced rat model of inflammation-driven PE).

    “prevented maternal hypertension and fetal/placental growth restriction”

    AnimalsLPS-induced rat model of inflammation-driven PE200 mg/kg/daygestational days 1-19females

    NAD⁺ depletion is central to placental dysfunction in an inflammatory subclass of preeclampsia

    Life science alliance

  2. Nicotinamide riboside prevents fetal growth restriction in rodent (LPS-induced rodent model of inflammatory-driven preeclampsia).

    “NR administration (200mg/kg/day) from gestational day (GD) 1-19 could prevent the development of maternal hypertension and fetal/placental growth restriction”

    AnimalsLPS-induced rodent model of inflammatory-driven preeclampsia200mg/kg/dayGD 1-19

    NAD + depletion and altered mitochondrial function are key to the establishment of placental dysfunction in an inflammatory-driven subclass of preeclampsia

    bioRxiv (Cold Spring Harbor Laboratory)Preprint

More on Nicotinamide riboside

3-monochloro-1,2-propanediol

upin mice1

1 study
  1. 3-monochloro-1,2-propanediol induces fetal growth restriction in mice (gestational exposure).

    “3-Monochloro-1,2-propanediol (3-MCPD), a common food contaminant, induces fetal growth restriction in mice by triggering senescence in the placental vasculature.”

    Animalsgestational exposureplacental vasculature

    Food contaminant restricts fetal growth in mice

    Journal of agricultural and food chemistry

More on 3-monochloro-1,2-propanediol

S-adenosylhomocysteine

downin mice1

1 study
  1. S-adenosylhomocysteine decreases fetal growth restriction in mice (upon environmental Cd).

    “in vivo its inhibitor S-Adenosylhomocysteine treatment blocked the activation of CLPP-dependent mitochondrial protease stress, attenuating placental cellular senescence and FGR upon environmental Cd”

    Animalsupon environmental Cd

    Environmental cadmium drives placental senescence and fetal growth restriction via activating CLPP-dependent mitochondrial stress

    Journal of hazardous materials

More on S-adenosylhomocysteine

Cadmium

upin mice1

1 study
  1. Cadmium induces fetal growth restriction in mice (environmental Cd exposure).

    “environmental Cd degraded mitochondrial anti-aging protein SIRT3 to evoke placental cellular senescence and FGR”

    Animalsenvironmental Cd exposure

    Environmental cadmium drives placental senescence and fetal growth restriction via activating CLPP-dependent mitochondrial stress

    Journal of hazardous materials

More on Cadmium

MOTS-c

downin mice1

1 study
  1. MOTS-c protects against fetal growth restriction in hypoxia-induced IUGR mice.

    “The administration of MOTS‐c (5 mg/kg) significantly attenuated hypoxia‐induced IUGR by promoting placental angiogenesis and inhibiting oxidative stress‐mediated placental dysfunction.”

    Animalsin hypoxia-induced IUGR mice5 mg/kg

    MOTS‑c protects against placental injury via Nrf2 activation in hypoxia‑induced intrauterine growth restriction mice

    International journal of molecular medicine

More on MOTS-c

Nicotinamide mononucleotide

downin pigs1

1 study
  1. Nicotinamide mononucleotide decreases fetal growth restriction in pigs (maternal supplementation in sows).

    “NMN supplementation significantly reduced the IUGR rate”

    Animalsmaternal supplementation in sows0.2 g per dayfemalesn = 24

    Maternal β-Nicotinamide Mononucleotide Supplementation Reduces the IUGR Rate by Improving Mitochondrial Function in the Placenta of Sows via AMPK/PGC-1α Pathway

    Molecular nutrition & food research

More on Nicotinamide mononucleotide

Effects

3

Arterial compliance

downin humans1

1 study
  1. Fetal growth restriction decreases arterial compliance in humans (growth restricted cohorts).

    “Similar findings of impaired arterial compliance have been noticed across age groups (neonates through to adults).”

    Reviewgrowth restricted cohorts

    Influence of accelerated arterial aging in growth-restricted cohorts on adult-onset cardiovascular diseases

    American journal of physiology. Heart and circulatory physiology

More on Arterial compliance

IFN-γ

upin humans1

1 study
  1. Fetal growth restriction is linked with higher IFN-γ in humans (intrauterine growth restriction) (4.6 pg/mL ± 2.2 vs. 2.17 pg/mL ± 0.8; p = 0.002).

    “IFN-γ was significantly increased in IUGR (4.6 pg/mL ± 2.2 vs. 2.17 pg/mL ± 0.8; p = 0.002) compared with controls.”

    Humansintrauterine growth restrictionplasmafemalesn = 6

    Heterogenous Differences in Cellular Senescent Phenotypes in Pre-Eclampsia and IUGR following Quantitative Assessment of Multiple Biomarkers of Senescence

    International journal of molecular sciences

More on IFN-γ

Cardiac telomere length

downin rats1

1 study
  1. Fetal growth restriction decreases cardiac telomere length in rats (induced by bilateral uterine vessel ligation).

    “Growth restriction shortened cardiac telomere length ( P < 0.001)”

    Animalsinduced by bilateral uterine vessel ligationheartmales

    Fetal growth restriction shortens cardiac telomere length, but this is attenuated by exercise in early life

    Physiological genomics

More on Cardiac telomere length

Upstream

2

NFE2L2

is required forin mice1

1 study
  1. NFE2L2 is required for fetal growth restriction in mice (for MOTS-c protective effects in hypoxia-induced IUGR).

    “Furthermore, these protective effects exerted by MOTS‐c were dependent on Nrf2 activation, as administration of MOTS‐c had no protective role in Nrf2 KO mice”

    Animalsfor MOTS-c protective effects in hypoxia-induced IUGR

    MOTS‑c protects against placental injury via Nrf2 activation in hypoxia‑induced intrauterine growth restriction mice

    International journal of molecular medicine

More on NFE2L2

GINS3

upin mice1

1 study
  1. GINS3 induces fetal growth restriction in mice (homozygous for a D24 variant).

    “mouse embryos homozygous for a D24 variant presented intrauterine growth retardation and did not survive to birth”

    Animalshomozygous for a D24 variant

    Hypomorphic GINS3 variants alter DNA replication and cause Meier-Gorlin syndrome

    JCI insight

More on GINS3

Associations

12

Cerebral infarction/ischemic stroke

upin humans1HR 1.33

1 study
  1. Fetal growth restriction is associated with cerebral infarction/ischemic stroke in humans (Model 2: HR 1.33, 95% CI 1.06–1.68; Model 1: HR 1.38, 95% CI 1.09–1.74).

    “FGR in a first pregnancy is associated with increased maternal composite cardiovascular risk, including heart failure, acute myocardial infarction and cerebral infarction/ischemic stroke”

    HumansFirst singleton pregnancy; Model 2 adjusted for pre-existing and pregnancy-related cardiovascular risk factorsWithin 5 years postpartumfemales

    Five‐year risk of cardiovascular events in women with history of pregnancy complicated by fetal growth restriction

    Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology

More on Cerebral infarction/ischemic stroke

Acute myocardial infarction

upin humans1HR 1.53

1 study
  1. Fetal growth restriction is associated with acute myocardial infarction in humans (Model 2: HR 1.53, 95% CI 1.15–2.05; Model 1: HR 1.55, 95% CI 1.16–2.08).

    “FGR in a first pregnancy is associated with increased maternal composite cardiovascular risk, including heart failure, acute myocardial infarction and cerebral infarction/ischemic stroke”

    HumansFirst singleton pregnancy; Model 2 adjusted for pre-existing and pregnancy-related cardiovascular risk factorsWithin 5 years postpartumfemales

    Five‐year risk of cardiovascular events in women with history of pregnancy complicated by fetal growth restriction

    Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology

More on Acute myocardial infarction

Heart failure

upin humans1HR 1.3

1 study
  1. Fetal growth restriction is associated with heart failure in humans (Model 2: HR 1.30, 95% CI 1.09–1.56; Model 1: HR 1.29, 95% CI 1.08–1.54).

    “FGR in a first pregnancy is associated with increased maternal composite cardiovascular risk, including heart failure, acute myocardial infarction and cerebral infarction/ischemic stroke”

    HumansFirst singleton pregnancy; Model 2 adjusted for pre-existing and pregnancy-related cardiovascular risk factorsWithin 5 years postpartumfemales

    Five‐year risk of cardiovascular events in women with history of pregnancy complicated by fetal growth restriction

    Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology

More on Heart failure

Composite maternal cardiovascular outcome

upin humans1HR 1.31

1 study
  1. Fetal growth restriction is associated with composite maternal cardiovascular outcome in humans (Model 2: HR 1.31, 95% CI 1.15–1.50; Model 1: HR 1.33, 95% CI 1.16–1.52).

    “FGR was associated with an increased risk of the composite cardiovascular outcome”

    HumansFirst singleton pregnancy; Model 2 adjusted for pre-existing and pregnancy-related cardiovascular risk factorsWithin 5 years postpartumfemales

    Five‐year risk of cardiovascular events in women with history of pregnancy complicated by fetal growth restriction

    Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology

Cellular senescence

upin reviews1

1 study
  1. Cellular senescence is associated with fetal growth restriction.

    “Placental insufficiency is the primary etiology, and accumulating evidence identifies premature trophoblast senescence as a central pathogenic mechanism.”

    Reviewplacenta

    Placental Senescence in Fetal Growth Restriction: Molecular Mechanisms, Biomarkers, and Therapeutic Implications

    Frontiers in cell and developmental biology

More on Cellular senescence

Atherosclerosis

upin humans1

1 study
  1. Fetal growth restriction is associated with atherosclerosis in humans (Maternal cardiovascular risk after pregnancy).

    “after FGR the increased risk of atherosclerosis was most notable.”

    HumansMaternal cardiovascular risk after pregnancyfemales

    Pregnancy complications linked to heart and blood vessel disease

    BJOG : an international journal of obstetrics and gynaecology

More on Atherosclerosis

Cardiac arrhythmias and conduction disorders

upin humans1HR 1.18

1 study
  1. Fetal growth restriction is associated with cardiac arrhythmias and conduction disorders in humans (Primiparous women) (Adjusted HR 1.18, 95% CI 1.04–1.34).

    “and fetal growth restriction (HRadj 1.18, 95% CI 1.04-1.34).”

    HumansPrimiparous womenMedian follow-up of 14 yearsfemales

    Adverse pregnancy outcomes and long-term risk of cardiac arrhythmias and conduction disorders: a nationwide cohort study

    ESC Congress 2026 abstract

More on Cardiac arrhythmias and conduction disorders

Cardiovascular events

upin humans1

1 study
  1. Fetal growth restriction is associated with cardiovascular events in humans (compared to pregnancies without complications) (p = 7.6 × 10 -6).

    “women who later delivered growth-restricted infants had composite protein signatures associated with reduced cardiac function (p = 0.001), increased cardiovascular events (p = 7.6 × 10 -6 )”

    Humanscompared to pregnancies without complicationsplasma36 weeks' gestation

    Proteomic signatures during pregnancy: an exploratory cohort study of long-term health indicators

    EBioMedicine

Mid-life dementia

upin humans1

1 study
  1. Fetal growth restriction is associated with mid-life dementia in humans (compared to pregnancies without complications) (p = 1.5 × 10 -9).

    “women who later delivered growth-restricted infants had composite protein signatures associated with reduced cardiac function (p = 0.001), increased cardiovascular events (p = 7.6 × 10 -6 ), mid-life dementia”

    Humanscompared to pregnancies without complicationsplasma36 weeks' gestation

    Proteomic signatures during pregnancy: an exploratory cohort study of long-term health indicators

    EBioMedicine

More on Mid-life dementia

Mortality

upin humans1

1 study
  1. Fetal growth restriction raises the risk of mortality in humans (30%-50% increase).

    “Preterm birth and fetal growth restriction (FGR) are independently associated with reduced nephron endowment, impaired cardiac and pulmonary development, and metabolic dysfunction, and with a 30%-50% increase in all-cause mortality risk”

    Review

    The womb as the cradle of longevity: Perinatal origins of biological aging

    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics

All 12

Trial sponsors

Funding

2 grants since 2025

Japan Society for the Promotion of Science¥4.7MSwiss National Science FoundationCHF 900K

Latest

Dec 2025: 0Jan 2026: 3Feb 2026: 3Mar 2026: 1Apr 2026: 1May 2026: 1Jun 2026: 1Jul 2026: 3Aug 2026: 2Sep 2026: 7Oct 2026: 2Nov 2026: 529 papers in 12 months
BJOG

Pregnancy complications linked to heart and blood vessel disease

Women with these complications had a higher relative rate of heart and blood vessel disease than women without them, with an adjusted hazard ratio of 1.70.Women with these complications had a higher relative rate of heart and blood vessel disease than women without them, with an adjusted hazard ratio of 1.70.

Cohort · 1,669,681 peoplePopulations
Journal of Agricultural and Food Chemistry

Food contaminant restricts fetal growth in mice

Mouse experiments linked restricted fetal growth to senescence, a state in which cells stop dividing, in the placenta’s blood vessels.Mouse experiments linked restricted fetal growth to senescence, a state in which cells stop dividing, in the placenta’s blood vessels.

Mouse studyMechanisms

See all 77 papers on fetal growth restriction